Zanganeh Mahkam
SEC CIK 1507650 · EDGAR
BoughtSold
Most active insiders at SMMT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zanganeh Mahkam | Co-CEO, Dir, 10% | $51.95M | — |
| 2 | DUGGAN ROBERT W | Co-CEO, Dir, 10% | $51.95M | — |
| 3 | Xia Yu | Dir | $10.00M | — |
| 4 | Soni Manmeet Singh | COO, CFO, Dir | $722.2K | — |
| 5 | Anand Bhaskar | CAO | — | — |
Transactions 26
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-06-12 14:35 | 2026-06-12 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Co-CEO, Dir, 10% | P - Purchase | $13.12 | +3.81M | 573.88M | +0.7% | +$49.99M |
| I | 2026-06-04 17:45 | 2026-06-04 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Co-CEO, Dir, 10% | P - Purchase | $14.60 | +100.0K | 25.82M | +0.4% | +$1.46M |
| MI | 2025-10-23 | 2025-10-21 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Co-CEO, Dir, 10% | A - Grant | $18.74 | +14.25M | 570.07M | +3% | +$267.00M |
| I | 2025-10-23 | 2025-10-21 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Co-CEO, Dir, 10% | P - Purchase | $18.74 | +26.7K | 76.7K | +53% | +$500.0K |
| MI | 2025-09-11 | 2025-09-10+ | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Co-CEO, Dir, 10% | P - Purchase | $17.69 | +338.4K | 556.09M | +0.1% | +$5.98M |
| DI | 2025-06-02 | 2025-05-30 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Co-CEO, Dir, 10% | M - OptEx | $2.64 | +74.5K | 555.75M | +0.0% | +$196.8K |
| DI | 2025-04-09 | 2025-04-08 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Co-CEO, Dir, 10% | X - OptEx | $1.58 | +3.99M | 555.68M | +0.7% | +$6.30M |
| DM | 2025-02-11 | 2025-01-24+ | PLSE | PULSE BIOSCIENCES, INC. | Zanganeh Mahkam | Dir | X - OptEx | $11.00 | +60.2K | 725.4K | +9% | +$662.7K |
| DI | 2024-10-03 | 2024-10-03 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Co-CEO, Dir | X - OptEx | $1.58 | +315.7K | 10.20M | +3% | +$498.8K |
| I | 2024-09-13 | 2024-09-11 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Co-CEO, Dir | A - Grant | $22.70 | +44.1K | 24.97M | +0.2% | +$1000.0K |
| D | 2024-07-09 | 2024-07-03 | PLSE | PULSE BIOSCIENCES, INC. | Zanganeh Mahkam | Dir | X - OptEx | — | +60.2K | 665.2K | +10% | — |
| MI | 2024-03-27 | 2024-03-26+ | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | CEO, Dir | P - Purchase | $3.73 | +84.3K | 24.92M | +0.3% | +$314.4K |
| 2024-03-27 | 2024-03-27 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | CEO, Dir | P - Purchase | $3.72 | +26.0K | 520.8K | +5% | +$96.7K | |
| DI | 2023-12-13 | 2023-12-11 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | CEO, Dir | X - OptEx | $1.58 | +315.7K | 24.89M | +1% | +$498.8K |
| D | 2023-12-13 | 2023-12-12 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | CEO, Dir | P - Purchase | $2.07 | +5,000 | 494.8K | +1% | +$10.3K |
| D | 2023-12-13 | 2023-12-11 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | CEO, Dir | X - OptEx | $1.44 | +489.8K | 489.8K | New | +$705.3K |
| DM | 2023-11-15 | 2023-11-13 | PLSE | PULSE BIOSCIENCES, INC. | Zanganeh Mahkam | Dir | M - OptEx | $2.14 | +76.1K | 604.9K | +14% | +$162.8K |
| DA | 2023-07-06 | 2023-06-09 | PLSE | PULSE BIOSCIENCES, INC. | Zanganeh Mahkam | Dir | X - OptEx | $2.05 | +86.7K | 528.8K | +20% | +$177.7K |
| D | 2023-06-13 | 2023-06-09 | PLSE | PULSE BIOSCIENCES, INC. | Zanganeh Mahkam | Dir | X - OptEx | $2.05 | +86.7K | 791.9K | +12% | +$177.7K |
| MAI | 2023-03-13 | 2023-03-08 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Pres, Co-CEO, Dir | P - Purchase | $1.05 | +23.53M | 9.88M | New | +$24.70M |
| 2023-03-08 | 2023-03-08 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Co-CEO, Dir | P - Purchase | $1.05 | +15.97M | 23.40M | +215% | +$16.77M | |
| MI | 2023-03-08 | 2023-03-08 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Co-CEO, Dir | P - Purchase | $1.05 | +7.55M | 1.18M | New | +$7.93M |
| 2022-12-09 | 2022-12-06 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | Pres, Co-CEO, Dir | J - Other | — | +373.9K | 10.93M | +4% | — | |
| MI | 2022-08-18 | 2022-08-16 | SMMT | Summit Therapeutics Inc. | Zanganeh Maky | Pres, Co-CEO, Dir | P - Purchase | $0.97 | +5.62M | 3.14M | New | +$5.46M |
| 2022-08-18 | 2022-08-16 | SMMT | Summit Therapeutics Inc. | Zanganeh Maky | Pres, Co-CEO, Dir | P - Purchase | $0.97 | +184.4K | 360.0K | +105% | +$178.9K | |
| D | 2022-06-10 | 2022-06-09 | PLSE | PULSE BIOSCIENCES, INC. | Zanganeh Maky | Dir | X - OptEx | — | +86.7K | 442.2K | +24% | — |
Purchase Sale Sale after option exercise All abbreviations